NYSE:MDT - Medtronic Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $144.21
  • Forecasted Upside: 29.86 %
  • Number of Analysts: 21
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 16 Buy Ratings
  • 0 Strong Buy Ratings
▼ -3.39 (-2.96%)

This chart shows the closing price for MDT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Medtronic Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MDT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MDT

Analyst Price Target is $144.21
▲ +29.86% Upside Potential
This price target is based on 21 analysts offering 12 month price targets for Medtronic in the last 3 months. The average price target is $144.21, with a high forecast of $165.00 and a low forecast of $119.00. The average price target represents a 29.86% upside from the last price of $111.05.

This chart shows the closing price for MDT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 21 polled investment analysts is to buy stock in Medtronic. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 23 buy ratings
  • 6 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 21 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 20 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 19 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 17 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 15 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/24/2021Truist SecuritiesLower Price TargetBuy$148.00 ➝ $142.00Low
11/24/2021TruistLower Price TargetBuy$148.00 ➝ $142.00Low
11/24/2021Morgan StanleyLower Price TargetOverweight$154.00 ➝ $145.00Low
11/24/2021Wells Fargo & CompanyLower Price TargetOverweight$144.00 ➝ $137.00Low
11/24/2021OppenheimerLower Price TargetOutperform$150.00 ➝ $145.00Low
11/24/2021CitigroupLower Price TargetBuy$153.00 ➝ $146.00Low
11/23/2021Needham & Company LLCLower Price TargetBuy$152.00 ➝ $145.00Medium
10/18/2021Wells Fargo & CompanyLower Price TargetPositive ➝ Overweight$151.00 ➝ $144.00High
8/27/2021ArgusBoost Price TargetPositive ➝ Buy$150.00 ➝ $165.00Low
8/25/2021TruistBoost Price TargetBuy$138.00 ➝ $148.00Low
8/25/2021Truist SecuritiesBoost Price TargetBuy$138.00 ➝ $148.00Low
8/25/2021Credit Suisse GroupBoost Price TargetOutperform$137.00 ➝ $146.00Medium
8/25/2021Wells Fargo & CompanyBoost Price TargetOverweight$140.00 ➝ $151.00Medium
8/25/2021Raymond JamesBoost Price TargetOutperform$135.00 ➝ $142.00Medium
8/25/2021Stifel NicolausBoost Price TargetBuy$140.00 ➝ $145.00Medium
8/25/2021UBS GroupBoost Price TargetBuy$145.00 ➝ $149.00Medium
8/25/2021Morgan StanleyBoost Price TargetPositive ➝ Overweight$140.00 ➝ $154.00Medium
8/25/2021CitigroupReiterated RatingFocus List$143.00 ➝ $153.00Medium
8/24/2021Piper SandlerReiterated RatingOverweight$140.00 ➝ $152.00Medium
8/9/2021BTIG ResearchDowngradeBuy ➝ NeutralLow
6/3/2021ArgusBoost Price TargetBuy$135.00 ➝ $150.00Low
5/28/2021SVB LeerinkBoost Price TargetMarket Perform$129.00 ➝ $138.00Medium
5/28/2021Raymond JamesBoost Price TargetOutperform$128.00 ➝ $135.00Medium
5/28/2021OppenheimerBoost Price TargetOutperform$134.00 ➝ $147.00Low
5/28/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$134.00 ➝ $149.00Medium
5/28/2021CitigroupReiterated RatingBuy$133.00 ➝ $143.00Medium
5/27/2021William BlairReiterated RatingMarket PerformN/A
5/27/2021Piper SandlerBoost Price TargetPositive ➝ Overweight$130.00 ➝ $140.00High
5/24/2021BarclaysInitiated CoverageEqual Weight$145.00Low
4/15/2021Atlantic SecuritiesInitiated CoverageOverweight$153.00Medium
3/2/2021SVB LeerinkBoost Price TargetMarket Perform$123.00 ➝ $129.00Low
2/25/2021Raymond JamesBoost Price TargetOutperform$122.00 ➝ $128.00Low
2/25/2021Credit Suisse GroupBoost Price TargetOutperform$126.00 ➝ $130.00Low
2/24/2021CowenBoost Price TargetOutperform$120.00 ➝ $135.00Low
2/24/2021SVB LeerinkReiterated RatingMarket Perform$123.00 ➝ $129.00Low
2/24/2021Stifel NicolausBoost Price TargetBuy$132.00 ➝ $135.00Low
12/15/2020The Goldman Sachs GroupUpgradeSell ➝ Neutral$100.00 ➝ $119.00Low
12/15/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$140.00Low
11/25/2020TruistBoost Price TargetMarket Perform ➝ Buy$128.00Low
11/25/2020Smith Barney CitigroupBoost Price Target$120.00 ➝ $128.00Low
11/25/2020UBS GroupBoost Price TargetBuy$123.00 ➝ $130.00Low
11/25/2020Credit Suisse GroupBoost Price TargetPositive ➝ Outperform$118.00 ➝ $126.00Low
11/25/2020OppenheimerBoost Price TargetOutperform$122.00 ➝ $128.00Low
11/25/2020Raymond JamesBoost Price TargetOutperform$115.00 ➝ $122.00Low
11/25/2020Morgan StanleyBoost Price TargetEqual Weight$111.00 ➝ $120.00Low
11/25/2020Stifel NicolausBoost Price TargetPositive ➝ Buy$125.00 ➝ $132.00Low
11/25/2020BTIG ResearchBoost Price TargetBuy$119.00 ➝ $124.00Low
11/25/2020SVB LeerinkBoost Price TargetMarket Perform$110.00 ➝ $123.00Low
11/24/2020Piper SandlerBoost Price TargetOverweight$120.00 ➝ $130.00Low
11/18/2020Wells Fargo & CompanyBoost Price TargetPositive ➝ Overweight$118.00 ➝ $127.00Medium
10/15/2020Jefferies Financial GroupBoost Price TargetBuy$120.00 ➝ $138.00Low
10/8/2020Sanford C. BernsteinUpgradeMarket Perform ➝ OutperformLow
10/8/2020Stifel NicolausUpgradeHold ➝ Buy$125.00Low
9/11/2020Wolfe ResearchInitiated CoveragePeer Perform$115.00Low
8/26/2020BTIG ResearchBoost Price TargetBuy$102.00 ➝ $111.00Low
8/26/2020SVB LeerinkBoost Price TargetMarket Perform$105.00 ➝ $110.00Low
8/26/2020Morgan StanleyBoost Price TargetEqual Weight$106.00 ➝ $111.00Low
8/26/2020Credit Suisse GroupBoost Price TargetOutperform$117.00 ➝ $118.00Low
8/26/2020Raymond JamesBoost Price TargetOutperform$107.00 ➝ $115.00Medium
8/26/2020CitigroupBoost Price TargetBuy$108.00 ➝ $120.00Low
8/25/2020OppenheimerReiterated RatingBuy$112.00Low
8/25/2020Needham & Company LLCBoost Price TargetBuy$113.00 ➝ $124.00Low
8/18/2020CowenReiterated RatingBuy$110.00Low
8/11/2020Piper SandlerReiterated RatingBuy$120.00Medium
7/15/2020Needham & Company LLCReiterated RatingBuy$113.00Low
7/2/2020Credit Suisse GroupReiterated RatingBuy$117.00N/A
5/27/2020SunTrust BanksLower Price Target$130.00 ➝ $105.00Medium
5/23/2020CSFBReiterated RatingBuy$117.00N/A
5/22/2020Credit Suisse GroupReiterated RatingBuy$117.00N/A
5/22/2020Bank of AmericaReiterated RatingBuy$130.00N/A
5/22/2020Jefferies Financial GroupBoost Price TargetBuy$110.00 ➝ $120.00Medium
5/22/2020OppenheimerLower Price TargetOutperform$131.00 ➝ $112.00Medium
5/22/2020UBS GroupLower Price TargetBuy$130.00 ➝ $118.00Medium
5/22/2020Morgan StanleyLower Price TargetEqual Weight$112.00 ➝ $106.00Medium
5/22/2020Raymond JamesLower Price TargetOutperform$110.00 ➝ $107.00Medium
5/22/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$123.00 ➝ $118.00Medium
5/21/2020OppenheimerInitiated CoverageBuy$131.00Low
5/21/2020Needham & Company LLCReiterated RatingBuy$113.00Low
5/21/2020Piper SandlerLower Price TargetOverweight$135.00 ➝ $120.00Low
5/21/2020CfraUpgradeBuy ➝ Strong-Buy$127.00 ➝ $121.00Low
5/14/2020DZ BankDowngradeBuy ➝ Hold$92.00Low
4/28/2020SVB LeerinkBoost Price TargetMarket Perform$100.00 ➝ $105.00Medium
4/23/2020Sanford C. BernsteinReiterated RatingHold$112.00Medium
4/22/2020Needham & Company LLCReiterated RatingBuy$109.00Low
4/22/2020Wells Fargo & CompanyLower Price TargetOverweight$130.00 ➝ $108.00High
4/9/2020JPMorgan Chase & Co.Lower Price TargetOverweight$128.00 ➝ $115.00Medium
4/9/2020Raymond JamesLower Price TargetOutperform$122.00 ➝ $110.00Medium
3/30/2020SunTrust BanksReiterated RatingBuy$130.00High
3/30/2020BTIG ResearchLower Price TargetHold ➝ Buy$124.00 ➝ $102.00Low
3/30/2020Needham & Company LLCDowngradeStrong-Buy ➝ Buy$134.00 ➝ $109.00Low
3/27/2020Morgan StanleyLower Price TargetEqual Weight$123.00 ➝ $112.00Low
3/27/2020CitigroupLower Price TargetBuy$124.00 ➝ $105.00Low
3/25/2020DZ BankUpgradeHold ➝ Buy$90.00High
3/6/2020Credit Suisse GroupLower Price TargetOutperform$126.00 ➝ $121.00Low
3/4/2020CitigroupInitiated CoverageBuy$124.00Medium
2/19/2020Raymond JamesBoost Price TargetOutperform$121.00 ➝ $122.00Low
2/19/2020BTIG ResearchLower Price TargetBuy$126.00 ➝ $124.00Low
2/18/2020Piper SandlerReiterated RatingBuy$135.00Low
2/18/2020CfraBoost Price TargetBuy$126.00 ➝ $127.00Medium
2/17/2020Credit Suisse GroupReiterated RatingBuy$126.00High
2/12/2020The Goldman Sachs GroupInitiated CoverageSell$118.00Medium
1/22/2020Piper SandlerBoost Price TargetOverweight$125.00 ➝ $135.00Low
1/16/2020UBS GroupBoost Price TargetBuy$127.00 ➝ $130.00Medium
1/7/2020SunTrust BanksInitiated CoverageBuy$130.00High
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$99.00Low
1/2/2020CitigroupDowngradeBuy ➝ NeutralMedium
1/2/2020GuggenheimUpgradeNeutral ➝ Buy$135.00Low
12/20/2019JPMorgan Chase & Co.Boost Price TargetOverweight$122.00 ➝ $128.00Low
12/17/2019Morgan StanleyBoost Price TargetEqual Weight$116.00 ➝ $123.00Low
11/25/2019ArgusBoost Price TargetBuy$135.00Low
11/20/2019Royal Bank of CanadaBoost Price TargetOutperform$118.00 ➝ $122.00Medium
11/20/2019OppenheimerBoost Price TargetOutperform$118.00 ➝ $123.00Medium
11/20/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy$118.00 ➝ $123.00Low
11/19/2019Piper Jaffray CompaniesBoost Price TargetOverweight$125.00Low
8/28/2019Needham & Company LLCReiterated RatingBuy$133.00Low
8/21/2019Bank of AmericaSet Price TargetBuy$118.00Medium
8/21/2019OppenheimerBoost Price TargetOutperform$110.00 ➝ $118.00Low
8/21/2019BMO Capital MarketsBoost Price TargetOutperform$107.00 ➝ $118.00Low
8/21/2019BarclaysBoost Price TargetOverweight$110.00 ➝ $117.00Low
8/21/2019Morgan StanleyBoost Price TargetEqual Weight$105.00 ➝ $111.00Low
8/21/2019UBS GroupBoost Price TargetOverweight ➝ Buy$112.00 ➝ $122.00Low
8/21/2019Raymond JamesBoost Price TargetOutperform$105.00 ➝ $118.00Low
8/21/2019Wells Fargo & CompanyBoost Price TargetOutperform$110.00 ➝ $120.00Low
8/21/2019Stifel NicolausBoost Price TargetHold$95.00 ➝ $112.00Low
8/21/2019BTIG ResearchBoost Price TargetBuy$120.00Low
8/21/2019Northland SecuritiesReiterated RatingHold$100.00Low
8/19/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy$100.00 ➝ $111.00Low
8/16/2019Royal Bank of CanadaSet Price TargetBuy$110.00Low
8/14/2019Morgan StanleyBoost Price TargetEqual Weight$100.00 ➝ $105.00Low
8/14/2019CowenReiterated RatingOutperform$99.00 ➝ $111.00Medium
7/23/2019Needham & Company LLCReiterated RatingBuyLow
7/15/2019OppenheimerSet Price TargetBuy$110.00Low
7/11/2019BarclaysBoost Price TargetOverweight$104.00 ➝ $110.00Low
6/20/2019Northland SecuritiesReiterated RatingHold$100.00Low
6/14/2019UBS GroupBoost Price TargetBuy$112.00Low
6/4/2019Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$100.00 ➝ $110.00Medium
5/28/2019Royal Bank of CanadaLower Price TargetOutperform$100.00Medium
5/27/2019Needham & Company LLCReiterated RatingBuy$121.00Medium
4/4/2019Wells Fargo & CompanyLower Price TargetMarket Perform ➝ Market Perform$101.00 ➝ $100.00Low
3/18/2019Northland SecuritiesReiterated RatingHold$84.00Low
2/25/2019CitigroupBoost Price TargetNeutral ➝ Neutral$95.00 ➝ $101.00Low
2/20/2019BarclaysReiterated RatingBuy$104.00Low
2/20/2019OppenheimerSet Price TargetBuy$104.00Low
2/4/2019Needham & Company LLCReiterated RatingStrong-Buy ➝ Strong-Buy$120.00 ➝ $117.00Low
1/15/2019BTIG ResearchUpgradeNeutral ➝ Buy$100.00Low
1/8/2019BarclaysLower Price TargetOverweight ➝ Overweight$113.00 ➝ $104.00Low
1/2/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$99.00High
1/2/2019Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$98.00 ➝ $102.00Low
1/2/2019CitigroupDowngradeBuy ➝ Neutral$109.00 ➝ $96.00Medium
12/19/2018JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$100.00 ➝ $109.00High
12/17/2018Credit Suisse GroupInitiated CoverageBuy ➝ Outperform$109.00 ➝ $109.00Low
11/28/2018UBS GroupInitiated CoverageBuy ➝ Buy$112.00Medium
11/21/2018Raymond JamesLower Price TargetOutperform ➝ Outperform$105.00 ➝ $104.00Medium
11/20/2018OppenheimerReiterated RatingBuy$104.00Medium
10/15/2018BarclaysInitiated CoverageOverweight ➝ Overweight$113.00Medium
10/8/2018ArgusBoost Price TargetBuy ➝ Buy$108.00 ➝ $120.00Medium
10/3/2018Royal Bank of CanadaBoost Price TargetOutperform$109.00Low
9/21/2018OppenheimerReiterated RatingBuyMedium
8/27/2018ArgusBoost Price TargetBuy ➝ Buy$95.00 ➝ $108.00Low
8/24/2018SunTrust BanksBoost Price TargetBuy$110.00Low
8/24/2018CitigroupBoost Price TargetBuy ➝ Buy$104.00 ➝ $109.00Low
8/22/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$98.00 ➝ $105.00Low
8/22/2018SVB LeerinkBoost Price TargetMarket Perform$95.00 ➝ $100.00Low
8/22/2018Royal Bank of CanadaBoost Price TargetOutperform$104.00Low
8/22/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$94.00 ➝ $104.00Low
8/22/2018Wells Fargo & CompanyBoost Price TargetMarket Perform ➝ Market Perform$95.00 ➝ $101.00Low
8/22/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$95.00 ➝ $105.00Low
8/22/2018Stifel NicolausBoost Price TargetHold ➝ Hold$87.00 ➝ $96.00Low
8/21/2018OppenheimerReiterated RatingBuy$104.00High
8/13/2018Needham & Company LLCUpgradeBuy ➝ Strong-Buy$103.00 ➝ $119.00Low
6/27/2018Sanford C. BernsteinInitiated CoverageMarket Perform$88.00Medium
6/6/2018William BlairInitiated CoverageOutperform ➝ Market PerformLow
6/6/2018OppenheimerSet Price TargetBuy$96.00Low
6/6/2018Needham & Company LLCBoost Price TargetBuy$97.00 ➝ $103.00Low
5/31/2018Raymond JamesInitiated CoverageOutperform$96.00Low
5/25/2018Piper Jaffray CompaniesBoost Price TargetOverweight$96.00Low
5/25/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$90.00 ➝ $95.00Low
5/24/2018OppenheimerReiterated RatingBuy$96.00Medium
5/21/2018SunTrust BanksBoost Price TargetBuy$96.00Low
4/27/2018Piper Jaffray CompaniesInitiated CoverageOverweight$90.00Medium
3/29/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$95.00 ➝ $90.00Medium
3/20/2018OppenheimerReiterated RatingBuyLow
2/22/2018CitigroupReiterated RatingBuy ➝ Buy$100.00 ➝ $93.00Low
2/20/2018OppenheimerReiterated RatingBuy$94.00Low
2/14/2018Royal Bank of CanadaReiterated RatingOutperform$92.00Medium
2/5/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$91.00 ➝ $95.00High
1/19/2018OppenheimerSet Price TargetBuy$94.00Low
1/3/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$92.50High
1/2/2018Bank of AmericaUpgradeNeutral ➝ BuyHigh
12/21/2017OppenheimerReiterated RatingBuyLow
12/12/2017ArgusUpgradeHold ➝ Buy$81.27 ➝ $95.00Low
12/12/2017BMO Capital MarketsBoost Price TargetOutperform$94.00Low
11/23/2017Jefferies Financial GroupReiterated RatingBuy$99.00N/A
11/22/2017Northland SecuritiesReiterated RatingHold$80.00N/A
11/22/2017OppenheimerReiterated RatingBuy$94.00N/A
11/22/2017Stifel NicolausBoost Price TargetHold$83.00 ➝ $85.00N/A
11/19/2017SunTrust BanksSet Price TargetBuy$92.00N/A
11/9/2017Needham & Company LLCReiterated RatingBuy$94.00N/A
11/3/2017SunTrust BanksReiterated RatingBuy$96.00N/A
11/3/2017CowenReiterated RatingBuy$95.00N/A
10/10/2017BMO Capital MarketsReiterated RatingOutperform$92.00 ➝ $89.00N/A
10/10/2017Needham & Company LLCLower Price TargetBuy$95.00 ➝ $94.00N/A
10/9/2017SVB LeerinkReiterated RatingMarket Perform$88.00 ➝ $85.00N/A
10/9/2017Stifel NicolausLower Price TargetHold$91.00 ➝ $83.00N/A
10/9/2017Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$90.00 ➝ $85.00N/A
10/9/2017Wells Fargo & CompanyDowngradeOutperform ➝ Market Perform$93.00 ➝ $83.00N/A
10/2/2017SunTrust BanksReiterated RatingBuy$96.00Low
9/28/2017Jefferies Financial GroupReiterated RatingBuy$96.00Low
8/24/2017UBS GroupReiterated RatingOverweightLow
8/23/2017Jefferies Financial GroupLower Price TargetBuy$103.00 ➝ $96.00Low
8/23/2017BarclaysLower Price TargetOverweight$94.00 ➝ $92.00Low
8/23/2017BMO Capital MarketsReiterated RatingOutperform$94.00 ➝ $92.00Low
8/22/2017CowenSet Price TargetBuy$95.00Low
8/22/2017OppenheimerReiterated RatingBuy$92.00Medium
8/21/2017Royal Bank of CanadaReiterated RatingBuy$90.00Low
8/3/2017Jefferies Financial GroupReiterated RatingBuy$103.00Low
7/31/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$96.00Low
7/18/2017OppenheimerReiterated RatingBuyLow
7/12/2017Wells Fargo & CompanyReiterated RatingOutperformLow
7/6/2017William BlairReiterated RatingOutperformMedium
5/30/2017BMO Capital MarketsBoost Price TargetOutperform$87.00 ➝ $94.00Low
5/30/2017UBS GroupReiterated RatingBuy$94.00 ➝ $95.00N/A
5/30/2017Morgan StanleyBoost Price TargetEqual Weight$84.00 ➝ $86.00Low
5/28/2017BarclaysReiterated RatingOverweight$92.00 ➝ $94.00Low
5/28/2017CowenReiterated RatingOutperform$86.00 ➝ $95.00Low
5/28/2017Stifel NicolausReiterated RatingHold$84.00 ➝ $91.00Low
5/28/2017Evercore ISIReiterated RatingOutperform$88.50 ➝ $91.00Low
5/26/2017CIBCReiterated RatingBuyLow
5/25/2017Needham & Company LLCReiterated RatingBuy ➝ Buy$91.00 ➝ $95.00Low
5/25/2017OppenheimerReiterated RatingBuy$87.00 ➝ $93.00Low
5/16/2017The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$87.00Low
4/20/2017Northland SecuritiesReiterated RatingHold$80.00Medium
4/19/2017Evercore ISIBoost Price TargetOutperform$88.00 ➝ $88.50Medium
4/18/2017OppenheimerReiterated RatingBuyLow
4/18/2017Royal Bank of CanadaReiterated RatingBuy$85.00Low
3/27/2017Needham & Company LLCReiterated RatingBuy$91.00Low
3/22/2017OppenheimerReiterated RatingBuyLow
3/20/2017BTIG ResearchReiterated RatingNeutralLow
2/23/2017OppenheimerReiterated RatingOutperform$84.00 ➝ $87.00N/A
2/23/2017SVB LeerinkBoost Price TargetMarket Perform$80.00 ➝ $85.00N/A
2/22/2017WedbushReiterated RatingNeutral$85.00N/A
2/21/2017Needham & Company LLCBoost Price TargetBuy ➝ Buy$84.00 ➝ $91.00N/A
2/21/2017Evercore ISIBoost Price TargetBuy$78.00 ➝ $88.00N/A
2/17/2017UBS GroupBoost Price TargetBuy$88.00 ➝ $94.00N/A
2/17/2017Jefferies Financial GroupReiterated RatingBuy$88.00N/A
2/6/2017Needham & Company LLCReiterated RatingBuy$84.00N/A
1/8/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$96.00N/A
1/3/2017Morgan StanleyReiterated RatingEqual Weight ➝ OverweightN/A
1/3/2017Bank of AmericaDowngradeBuy ➝ Neutral$78.00N/A
1/3/2017Morgan StanleyDowngradeOverweight ➝ Equal Weight$85.00 ➝ $77.00N/A
1/3/2017JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$84.00 ➝ $79.00N/A
11/28/2016Evercore ISIReiterated RatingBuy$94.00 ➝ $80.00N/A
(Data available from 11/27/2016 forward)

News Sentiment Rating

0.16 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 9 very positive mentions
  • 21 positive mentions
  • 2 negative mentions
  • 3 very negative mentions
  • 31 very positive mentions
  • 45 positive mentions
  • 8 negative mentions
  • 1 very negative mentions
  • 5 very positive mentions
  • 43 positive mentions
  • 10 negative mentions
  • 4 very negative mentions
  • 9 very positive mentions
  • 31 positive mentions
  • 4 negative mentions
  • 2 very negative mentions
  • 10 very positive mentions
  • 48 positive mentions
  • 13 negative mentions
  • 2 very negative mentions

Current Sentiment

  • 10 very positive mentions
  • 48 positive mentions
  • 13 negative mentions
  • 2 very negative mentions

Recent Stories by Sentiment

Medtronic logo
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consists of products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Minimally Invasive Technologies Group segment focuses on respiratory system, gastrointestinal tract, renal system, lungs, pelvic region, kidneys, and obesity diseases. The Restorative Therapies Group segment comprises of neurostimulation therapies and drug delivery systems for the treatment of chronic pain, as well as areas of the spine and brain, along with pelvic health and conditions of the ear, nose, and throat. The Diabetes Group segment offers insulin pumps, coninuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $111.05
Low: $110.78
High: $113.51

50 Day Range

MA: $122.46
Low: $111.05
High: $130.64

52 Week Range

Now: $111.05
Low: $110.06
High: $135.89


5,561,251 shs

Average Volume

4,482,313 shs

Market Capitalization

$149.24 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Medtronic?

The following sell-side analysts have issued research reports on Medtronic in the last year: Argus, Atlantic Securities, Barclays PLC, BTIG Research, Citigroup Inc., Cowen Inc, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Stifel Nicolaus, SVB Leerink LLC, The Goldman Sachs Group, Inc., Truist, Truist Securities, UBS Group AG, Wells Fargo & Company, William Blair, and Zacks Investment Research.
View the latest analyst ratings for MDT.

What is the current price target for Medtronic?

19 Wall Street analysts have set twelve-month price targets for Medtronic in the last year. Their average twelve-month price target is $144.21, suggesting a possible upside of 29.9%. Argus has the highest price target set, predicting MDT will reach $165.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $119.00 for Medtronic in the next year.
View the latest price targets for MDT.

What is the current consensus analyst rating for Medtronic?

Medtronic currently has 5 hold ratings and 16 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MDT will outperform the market and that investors should add to their positions of Medtronic.
View the latest ratings for MDT.

What other companies compete with Medtronic?

How do I contact Medtronic's investor relations team?

Medtronic's physical mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company's listed phone number is (531) 438-1700 and its investor relations email address is [email protected] The official website for Medtronic is www.medtronic.com.